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Abstract
Background: Variations in gene allele frequencies can contribute to differences in the prevalence
of some common complex diseases among populations. Natural selection modulates the balance
in allele frequencies across populations. Population differentiation (FST) can evidence environmental
selection pressures. Such genetic information is limited in Puerto Ricans, the second largest
Hispanic ethnic group in the US, and a group with high prevalence of chronic disease. We
determined allele frequencies and population differentiation for 101 single nucleotide
polymorphisms (SNPs) in 30 genes involved in major metabolic and disease-relevant pathways in
Puerto Ricans (n = 969, ages 45–75 years) and compared them to similarly aged non-Hispanic
whites (NHW) (n = 597).
Results: Minor allele frequency (MAF) distributions for 45.5% of the SNPs assessed in Puerto
Ricans were significantly different from those of NHW. Puerto Ricans carried risk alleles in higher
frequency and protective alleles in lower frequency than NHW. Patterns of population
differentiation showed that Puerto Ricans had SNPs with exceptional FST values in intronic, non-
synonymous and promoter regions. NHW had exceptional FST values in intronic and promoter
region SNPs only.
Conclusion: These observations may serve to explain and broaden studies on the impact of gene
polymorphisms on chronic diseases affecting Puerto Ricans.
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Background
Close to four million Puerto Ricans live in the United
States mainland, representing the second largest Hispanic
ethnic group after Mexican-Americans [1]. The few studies
on health status or disparities that have focused on Puerto
Ricans living on the US mainland consistently show
excess chronic health conditions for this population when
compared with non-Hispanic whites (NHW) and other
Hispanic subgroups [2,3]. In particular, Puerto Ricans
exhibit high prevalence of diabetes, heart disease, obesity,
depression, and cognitive and functional decline [4-9];
national data points to a 12.6% prevalence of diabetes in
Puerto Ricans aged 20 years or older [10], while close to
61% of Puerto Rican adults are overweight or obesity [7],
and an estimated 9.3% have depression [11].
The etiology of such conditions is multi-factorial, and
most likely, a combination of genetic, social and environ-
mental factors define the health disparities observed in
Puerto Ricans. Still, studies on the genetic contribution to
such conditions in this population are limited. Generaliz-
ing genetic risk to Puerto Ricans based on results obtained
from other Hispanic groups is inappropriate due to the
unique genetic background of this community, which is
quite different from other Hispanic populations studied
more often [12-14]. Furthermore, extrapolating results
from other broadly researched non-Hispanic populations
onto Puerto Ricans could lead to inaccurate conclusions
[14].
Several reports have discussed the importance of estimat-
ing gene allele frequency in epidemiological and genetic
association studies [15-17]. Notably, allele frequencies for
single nucleotide polymorphisms (SNPs) can vary by eth-
nic group, sometimes drastically [18]. Spielman et al.
recently showed that expression of individual genes dif-
fered significantly between ethnic populations, and that
variation in frequency of specific alleles accounted for
some of these differences in gene expression [19]. Such
variations in minor allele frequency (MAF), when map-
ping to or affecting genes pertinent to a given disease,
could translate into differences in the prevalence and inci-
dence of disease across ethnic groups [20]. Indeed, several
studies have shown differences in allele distribution of
SNPs in candidate genes for immune response and lipid
metabolism as well as cardiovascular disease and type 2
diabetes, [17,18,20-23]. Myles et al. suggest that SNPs
with a large difference in risk allele frequency between
populations are strong candidates to explain the varia-
tions in disease prevalence between those populations
[24]. These observations strongly suggest that Puerto
Ricans may also carry disease-associated alleles at frequen-
cies different from other ethnic groups, and that such dif-
ferences could play a role in the health disparities
documented in this population.
The level of population differentiation shown by diverse
ethnic groups is related to the variations in allele fre-
quency for genetic polymorphisms [20]. Natural selection
modulates the balance in allele frequencies across popu-
lations. Certain environmental conditions can act
through selective pressure to alter the frequency of a
genetic variant resulting in population-specific allele fre-
quencies. Genomic regions of an excess of ancestral diver-
gence between disease and non-disease groups indicates
selection signals [25], which allows identification of
genomic regions that contribute the risk of disease. Alter-
natively, the fixation index (FST) measure quantifies pop-
ulation differentiation and tests for evidence of selection
pressures, with higher values of FST indicating local posi-
tive adaptation and lower values suggesting negative or
neutral selection [26]. Several studies have shown that dif-
ferentiation can vary by chromosomal region and by func-
tion of the SNP. Olshen et al. reported regions in
chromosomes 2 and 6 with high local FST values that also
differed between ethnic groups [27]. In addition, higher
FST estimates have been reported for SNPs in functional or
coding regions than in non-functional or non-coding
SNPs [26,28]. Barreiro et al. have shown that non-synon-
ymous and 5'-UTR SNPs present extreme degrees of differ-
entiation and positive selection [29]. It has been proposed
that loci showing high FST values, or exceptional variance,
should be given high priority for association studies of
complex diseases and studies on local adaptation to envi-
ronmental effects [26,30]. Positively selected alleles
(those with high FST values) in disease-associated SNPs
could be responsible for differences between populations
in prevalence or progression of disease [24]. Although FST
values could denote other forces such as genetic drift, bot-
tleneck or founder effect in the population, it is still a use-
ful measure to identify genomic regions of potential
environmental interactions and association with disease.
Such measures of genetic diversity within a population of
Puerto Ricans have not been reported.
We have estimated the ancestry of the Puerto Rican popu-
lation as 57.2% European, 27.4% African, and 15.4%
Native American [31]. Population admixture could influ-
ence allele frequencies and thus disease prevalence. Given
the high prevalence of diabetes, hypertension, and obesity
in this population, the aim of this study was to examine
the differences in allele frequencies of 101 disease-associ-
ated genetic variants in genes of pathways involving lipid
and glucose metabolism and inflammation response,
between Puerto Ricans and a non-Hispanic white popula-
tion, which has a much lower prevalence of such condi-
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tions and comprise the major ancestry population for
Puerto Ricans. In addition, we aimed to identify patterns
of population differentiation for Puerto Ricans in compar-
ison to NHW.
Methods
Study populations
The Puerto Rican sample consisted of unrelated partici-
pants of the Boston Puerto Rican Health Study, a cohort
of 1020 Puerto Rican subjects at the time of this analysis,
designed to study stress, nutrition, health and aging [32].
Eligible subjects were of Puerto Rican descent, between
the ages of 45–75, living in the Boston, MA metropolitan
area and able to answer interview questions in either Eng-
lish or Spanish. Subjects self-reported their ethnicity. This
study obtained Human Investigation Review Board
approval from Tufts Medical Center. Participants pro-
vided written informed consent.
The NHW sample was comprised of 1506 participants
over 18 years of age participating in the Genetics of Lipid
Lowering Drugs and Diet Network (GOLDN) Study. Par-
ticipants were recruited from the ongoing NHLBI Family
Heart Study in two genetically homogeneous centers
(Minneapolis, MN and Salt Lake City, UT) with predomi-
nantly NHW populations. Race was self-reported. The pri-
mary aim of the GOLDN study was to characterize the role
of genetic and dietary factors on an individual's response
to fenofibrate. The detailed design and methodology of
the study have been described previously [33]. The study
was approved by the Human Studies Committee of Insti-
tutional Review Board at the University of Alabama at Bir-
mingham, the University of Minnesota, University of
Utah, and Tufts Medical Center. Written informed con-
sent was obtained from all participants. To compare with
the Puerto Rican population, only data from 597 subjects
ages 45–75 years were selected.
Selection of genes and SNPs
Genes and SNPs were selected by bioinformatics analysis,
based on previously reported associations or knowledge
of their role in known biological pathways such as lipid
and glucose metabolism and inflammation response.
Briefly, SNP selection took a balanced approach of incor-
porating results of published studies, of bioinformatics-
based predictions of putative functional consequence of
the two alleles, and of linkage disequilibrium (LD) analy-
sis to diversely and economically sample different genetic
blocks. Putative allele-specific function was assessed
according to map position within the gene. SNPs in
upstream regions and introns were analyzed for altering
transcription factor binding sites. Intronic SNPs could
also affect mRNA splicing. Non-synonymous SNPs within
coding sequences of exons could alter protein sequence,
structure and function while synonymous SNPs could call
for codons of a different frequency whose effects can be
similar to non-synonymous SNPs. Lastly, 3'-UTR SNPs
can alter secondary structure which can affect mRNA sta-
bility or interactions with small RNAs (e.g., miRNAs).
These approaches are detailed elsewhere [34]. A total of
101 autosomal diallelic SNPs from 30 different genes
were genotyped. For each SNP, data for the SNP location
on the gene and chromosome, function and accession
number were obtained from databases published by the
National Center for Biotechnology Information [35].
Available information on reported associations with
chronic and metabolic conditions was collected by search-
ing the biomedical literature [35]. Only associations for
the individual allele or genotype and for healthy adults in
the general population were collected, unless otherwise
noted. Associations deemed conflicting were not included
unless a meta-analysis was available. A list of all geno-
typed SNPs, with information on chromosome location,
variant name, function, and accession number, is
included in Additional file 1.
Genotyping
Buffy coats of nucleated cells were obtained from blood
samples and genomic DNA was purified using the
QIAamp® DNA Blood Mini kits (Qiagen, Hilden, Germany)
according to the vendor's recommended protocol. Geno-
typing was carried out by the 5'-nuclease assay with allele
specific TaqMan probes [36]. TaqMan® SNP genotyping
assays, either custom (assays-by-design) or pre-designed
(assays-on-demand), were purchased from Applied Bio-
systems (Applied Biosystems, Foster City, CA). For each reac-
tion, 10 ng of DNA were diluted and aliquoted into 96-
well plates. Rapidplate robotic system was used in adding
DNA samples from 96-well plates into 384-well plates.
For PCR, the DNA was mixed with Taqman Universal PCR
MasterMix, Assay and water using a TECAN robotic sys-
tem. PCR cycles were (1) 10 min at 95°, (2) 15 seconds at
92° and (3) one minute at 60°; repeating steps 2 and 3 for
50 cycles. Blinded no-template controls and replicates of
DNA samples were included in the DNA sample plates
and routinely checked by the laboratory technicians.
Applied Biosystems 7900 was used for allelic discrimina-
tion, and Microsoft® Excel macros were used to create the
plate records with allele base codes and for cleaning data
including: checking on negative controls to ensure the
match of plate record and plate, allele frequency calcula-
tion to ensure the match of marker name and assay used,
and preparation of data ready for export into database.
Microsoft® Access was used for data consolidation to
ensure accuracy. Quality control estimated the genotyping
error rate as less than 1%. The descriptions for primers,
probes, and sequences, as well as ABI assay-on-demand
ID, are presented in Additional file 1.
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Statistical analysis
Statistical analyses were performed in SPSS version 15.0
or Microsoft® Excel. Allele frequencies were estimated
based on genotype frequencies. The Puerto Rican sample
was analyzed first and minor alleles were assigned based
on this population; thus Puerto Ricans have no minor
allele frequency greater than 0.50. To calculate the
expected MAF of each SNP under an admixture model in
Puerto Ricans, we first estimated allele frequency contri-
bution from the European ancestry (57%) and African
ancestry (27%) [31], based on the allele frequencies of 73
SNP available in HapMap for the CEU and YRI popula-
tion reported. As allele frequencies of Native American are
not available in HapMap or other sources, we estimated
the contribution from Native American ancestry by sub-
tracting the contribution of the European and African
ancestries from the observed allele frequencies. The pre-
dicted MAF under an admixed model was equal to the
sum of contribution from the three ancestries. Pearson's
chi-square statistic was used to test Hardy-Weinberg Equi-
librium (HWE) for each SNP and to calculate the differ-
ences in genotype and allele distributions between Puerto
Rican and NHW populations and between the observed
and the predicted MAF in Puerto Ricans under an admix-
ture model. Mann-Whitney and Wilcoxon non-paramet-
ric tests were used to evaluate statistical differences in MAF
and FST means between populations and by SNP function.
Frequencies and HWE were corroborated on PowerMarker
software [37] and no discrepancies were found with the
original results. PowerMarker was used to obtain popula-
tion-specific and between-population FST values (based
on the variance of allele frequencies about the means for
the population or between populations) for Puerto Rican
and NHW populations; the procedure for such measures
was formulated in Weir and Hill [38]. Negative FST values
were designated as zero, as they cannot be interpreted bio-
logically [39]. Tests between Puerto Rican and NHW pop-
ulations were deemed statistically significant at P <
0.0005, after a Bonferroni correction for multiple compar-
isons (101 tests); tests at P < 0.0007 were deemed signifi-
cant for our Puerto Rican sample and the predicted Puerto
Rican MAF under an admixture model.
Results
Genotyping data were available for a total of 969 Puerto
Rican subjects and 597 NHW subjects. More than 90% of
the available samples were genotyped successfully for all
but one SNP (FABP1 m2353 in NHW). The two popula-
tions were similar in age (mean ± standard deviation =
57.9 ± 7.3 for Puerto Ricans, 57.6 ± 9.2 for NHW), but dif-
fered in the distribution of sex, with Puerto Ricans having
more female subjects than NHW (72.0% versus 52.6%,
respectively). However, females represented the majority
of subjects for each group.
For each SNP, the genotype distribution, minor allele fre-
quency, sample size, and p-value from chi-square test for
difference in genotype distribution and allele frequency
among the two populations are detailed (Additional file
2). Frequencies did not differ by sex (data not shown).
Twelve SNPs in the Puerto Rican group and ten in the
NHW group were not in HWE at P < 0.05. After Bonfer-
roni adjustment for multiple tests, two SNPs were out of
HWE: APOC3 3U386 (rs5128) in Puerto Ricans, and
FABP1 m2353 (rs3891700) in both populations. As the
genotyping error rate was less than 1%, the lack of HWE
could be attributed to chance or to small sample size.
None of the SNPs were removed from subsequent analy-
sis.
Of the 101 SNPs, 46 (45.5%) showed allele frequency dis-
tributions that were significantly different between the
two populations at the P < 0.0005 level. Genotype fre-
quencies were significantly different for 41 SNPs. When
comparing the observed Puerto Rican MAF versus the pre-
dicted MAF under an admixed model, 24 of the 73
Table 1: Mean, standard deviation (SD), and range for MAF and FST by SNP function
SNP function Number of SNPs Puerto Rican non-Hispanic white
Mean (SD) MAF Mean (SD) FST Range FST Mean (SD) MAF Mean (SD) FST Range FST
3'UTR 5 0.20 (0.10) 0.022 (0.050) 0.112 0.19 (0.14) 0.050 (0.067) 0.141
Intron 37 0.31 (0.13) 0.019 (0.029) 0.131 0.29 (0.13) 0.019 (0.032) 0.134
Non-Synonymous 27 0.15 (0.10)1 0.041 (0.061) 0.255 0.16 (0.12)2 0.033 (0.053) 0.166
Promoter 22 0.30 (0.15) 0.022 (0.061) 0.290 0.27 (0.15) 0.033 (0.058) 0.250
Synonymous 8 0.28 (0.14) 0.036 (0.061) 0.177 0.32 (0.18) 0.013 (0.029) 0.085
1 Significantly different from Puerto Rican intron (p < 0.001), promoter (p = 0.001), synonymous SNPs (p = 0.015)
2 Significantly different from NHW intron (p < 0.001), promoter (p = 0.014), synonymous SNPs (p = 0.027)
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(32.9%) SNPs with available data showed significantly
different allele frequencies (Additional file 3). Table 1
shows the mean (standard deviation) MAF for Puerto
Ricans and NHW by SNP function. There were no statisti-
cally significant differences in mean MAF between popu-
lations by SNP function. However, for both populations,
non-synonymous SNPs had significantly lower MAF than
intronic, promoter or synonymous SNPs. Secondary anal-
ysis stratifying by chromosome showed that the SNPs in
genes mapping to chromosome 8 had significantly lower
mean MAF than most chromosomes in both populations,
and that for Puerto Ricans, SNPs in chromosome 3 had
lower mean MAF than chromosome 2; Puerto Ricans had
significantly higher MAF and lower FST for SNPs in chro-
mosome 4 than NHW (data not shown).
To determine if MAF were over- or under-represented on
disease-associated SNPs, alleles were categorized as being
either protective or risk based on previously reported asso-
ciations with prevalence or progression of disease. Figure
1 shows the MAF plotted for each population for those
alleles classified as either protective or risk, as well as a
description of the phenotypes associated with only those
SNPs for which MAF is significantly different between
populations at the P < 0.0005 level. Puerto Ricans showed
significantly lower frequency of the protective minor
allele than NHW in four of the nine SNPs examined,
including PPARG P12A, GCKR i21532, APOA2 m265 and
SCARB1 A350A. These SNPs have been associated with
increased high density lipoprotein (HDL-C) and reduced
risk or prevalence of type 2 diabetes and coronary disease.
Only one protective allele was significantly more frequent
in Puerto Ricans, PLIN i5496, which has been associated
with lower BMI. The remaining four SNPs did not have
significantly different allele distributions between the two
populations. For the risk minor alleles, Puerto Ricans
showed significantly greater frequency in six of the four-
teen examined SNPs. Mainly present in genes of lipid met-
abolic pathways (APOA5, APOB, APOC3 and LPL), the
higher frequency of risk alleles in Puerto Ricans has been
associated previously in other populations with unfavora-
ble lipid profile and insulin response, cardiovascular con-
ditions and metabolic syndrome. Only one SNP had
significantly lower frequency of the risk allele in Puerto
Ricans than NHW, APOB T2515T. The remaining seven
SNPs did not have significantly different MAF between
populations. Analysis of the 78 SNPs alleles with no con-
clusive evidence of risk or protection to disease, did not
present any differential pattern in MAF distribution
between the two populations (data not shown).
Additional file 3 lists the FST values for both populations.
The population-specific FST was 0.008 for Puerto Rican
and 0.039 for NHW, with a between-population FST of
0.020. The between-population FST suggests that the two
populations have little differentiation for the markers
tested. Population-specific FST has been suggested as the
best indicator of selection over between-population FST
[30]; thus, we examined the population-specific FST of
each SNP for signals of selection. Table 1 shows the mean
(standard deviation) and range for FST for Puerto Ricans
and NHW by SNP function. There were no statistical dif-
ferences in FST between populations or by SNP function.
Weir et al. have suggested that when the range of the pop-
ulation-specific value exceeds three standard deviations
from the mean, such values can be regarded as exception-
ally large and may indicate regions under selection [30].
To identify such exceptional values, Figure 2 shows the FST
range (filled circles) for Puerto Ricans (a) and NHW (b)
by SNP function, with open squares representing mean
FST and bars indicating three standard deviations from the
mean for each SNP function category. Exceptionally high
values in Puerto Ricans were observed in SNPs located in
intronic, non-synonymous and promoter regions, while
for NHW they were observed in intronic and promoter
SNPs. When stratifying by chromosome during secondary
analysis, exceptional FST values were positioned in chro-
mosome 11 for Puerto Ricans, while NHW did not show
any exceptional values (data not shown).
Discussion
The present study showed that a group of older adult
Puerto Ricans living in the United States had significantly
different allele frequency distribution in 101 single nucle-
otide polymorphisms than similarly aged NHW. Moreo-
ver, Puerto Ricans had lower frequency of protective
alleles and greater prevalence of risk alleles for SNPs asso-
ciated with several chronic diseases. Although population
differentiation values (FST) did not differ between the two
populations, the patterns of FST differed by SNP function
in the populations. Puerto Ricans showed exceptional FST
values in intronic, non-synonymous and promoter SNPs,
while NHW had exceptional values in intronic and pro-
moter SNPs only. These exceptional FST values suggest that
selection may be present in genes harboring those SNPs
[30].
The differences in allele frequency and population differ-
entiation between the two studied populations may seem
surprising as Puerto Ricans comprise an admixed popula-
tion with European, African and Native American (Taíno)
heritage [31]. The value of 45.5% of SNPs showing differ-
ence in MAF between the two populations reported here
is higher than such differences reported in other popula-
tions possibly more distant than Puerto Ricans and NHW.
Bamshad et al. found that 41% of SNPs differed signifi-
cantly between African Americans and European Ameri-
cans [40]. Moreover, Burchard et al. reported that studies
examining the allele frequency distribution among racial
BMC Genetics 2009, 10:45 http://www.biomedcentral.com/1471-2156/10/45
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Differences in protective (upper panel) or risk (lower panel) minor allele frequency in Puerto Rican versus non-Hispanic whites, by SNPFigu  1
Differences in protective (upper panel) or risk (lower panel) minor allele frequency in Puerto Rican versus 
non-Hispanic whites, by SNP. Tables describe the associated phenotypes for those SNPs with significantly different MAF 
between populations. *Significantly different MAF between populations, p < 0.0005 Abbreviations: MAF: minor allele frequency; 
HDL-C: high density lipoprotein; T2DM: type 2 diabetes mellitus; HOMA-IR: homeostasis model assessment of insulin resist-
ance; CAD: coronary artery disease; BMI: body mass index; TG: triglycerides; LDL-C: low density lipoprotein; VLDL-C: very 
low density lipoprotein; TC: total cholesterol; IHD: ischemic heart disease; CHD: coronary heart disease; HbA1c: glycosylated 
hemoglobin.
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Protective SNP Associated Phenotype References 
PPARG P12A ? HDL-C
? insulin sensitivity 
? insulin resistance 
? T2DM 
? early atherosclerosis 
[50], [51], [52], 
[53], [54], [55], 
[56]
GCKR i21532 ? HOMA-IR 
? T2DM 
? dyslipidemia [57] 
APOA2 m265 ? CAD ? postprandial response  [58], [59] 
SCARB1 A350A ? HDL-C [60]
PLIN i5496 ? BMI, weight and obesity  [61] 
Risk SNP Associated Phenotype References 
APOA5 m1123 CAD  
Metabolic syndrome  
? TG [62], [63], [64], 
[65], [66] 
APOA5 S16W Hyperlipoproteinemia ? TG [65], [66] 
LPL m107 ? TG 
? insulin
? LDL-C 
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? TC
? HDL-C 
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IHD
[67], [68], [69],
[70]
APOC3 3U386 ? TG
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? LDL-C
? TC 
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[71], [72], [73], 
[74]
APOB T2515T cholesterol gallstones 
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? TC and LDL-C 
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[75], [76], [77] 
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? TG
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[78], [79], [80] 
[81]
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groups had found differences of 15% to 20% between
groups [41]. Those authors argue that differences in fre-
quency among ethnic groups are typically not as large as
those we observed. It is possible that the origins of the
white component of the two populations studied here
contribute to some of the observed allele frequency differ-
ences. The NHW population shares ancestry primarily
with individuals from northern and western Europe,
while the Puerto Rican population shares ancestry prima-
rily with peoples of the Iberian Peninsula. To determine
the contribution of ancestral populations, we calculated
the predicted MAF for Puerto Ricans under an admixture
model. Close to a third of the SNPs with available data on
predicted MAF showed significantly different allele fre-
FST range (filled circle) for Puerto Ricans (a) and non-Hispanic whites (b) by SNP functionigure 2
FST range (filled circle) for Puerto Ricans (a) and non-Hispanic whites (b) by SNP function. Open squares repre-
sent mean FST and bars represent three standard deviations from the mean for each SNP function.
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quencies from our Puerto Rican sample, suggesting that
for those loci, the frequencies cannot be explained by
admixture alone. However, for the majority of the ana-
lyzed SNPs showing similar observed and expected MAF,
each ancestral population may be contributing unequal
allele frequencies, supporting our conclusion on the large
difference between our Puerto Rican sample and the
NHW population. The observation that the MAF in Puerto
Ricans tended to be lower for protective alleles and higher
for risk alleles in disease-associated SNPs is notable. This
could be an important factor in the disparities in chronic
diseases observed in Puerto Ricans.
Within genomic regions, other groups have found higher
MAF in non-coding regions than in coding regions,
reflecting the deleterious effect of mutations in coding
regions, with promoter regions having the highest MAF
[17]. Our observations agree with these previous results,
where non-synonymous SNPs have lower mean MAF than
SNPs with other functions. We obtained very low FST val-
ues for both populations, suggesting very little population
differentiation. To our knowledge, this is the first report of
population differentiation for Puerto Ricans. FST estimates
for other racial groups have been reported in a wide range
from 0.009 in Ashkenazi Jews and HapMap European
populations [27] to 0.11 for SNPs across four HapMap
populations [29]. The variations are most likely due to dif-
ferences in sample size and tested markers.
When assessing exceptional FST values by functional cate-
gories of the SNP, our study shows that Puerto Ricans had
exceptional FST values in intronic, non-synonymous and
promoter SNPs. Analysis of data from NHW exhibited a
preponderance of exceptional FST values in SNPs mapping
to intronic and promoter regions. In secondary analysis,
Puerto Ricans showed a prevalence of exceptional FST
SNPs mapping to chromosome 11. Interestingly, chromo-
some 11 includes four clustered apolipoprotein genes
(APOA1, APOA4, APOA5 and APOC3), for which several
gene-environment interactions have been reported. In a
study with a Puerto Rican sample, Tang et al. showed an
excess of Native American ancestry in chromosome 11,
which also harbors an olfactory gene cluster that is a target
of ongoing positive selection [25]. Kullo and Ding
showed high FST values for SNPs in genes of the blood cir-
culation and gas exchange pathways as well as the lipo-
protein metabolism pathway in African versus NHW or
Asian populations [26]. These observations agree with the
prospect that SNPs with high or exceptional FST values
should be considered priority candidates for studies on
association with complex diseases and local adaptation to
environmental influences. Future studies in these popula-
tions should focus on intronic, promoter and non-synon-
ymous SNPs for Puerto Ricans, and promoter and intronic
SNPs for NHW.
There are limitations to this study. First, the tested SNPs
were not randomly selected and thus the frequencies and
FST measures may not represent actual distributions, as
selective pressures may cause over- or under-representa-
tion in disease-associated genes. However, it has been
shown that disease-associated SNPs do not show greater
population differentiation than SNPs chosen at random
[42]. Here, a limited number of tested markers yielded
results that could be due to a particular selection. Addi-
tionally, statistical power might be limited when stratify-
ing by SNP function (or by chromosome in secondary
analysis). Nonetheless, other studies have reported simi-
lar measures using fewer SNPs [23,24]. Furthermore, FST
values can also indicate genetic drift and bottleneck effect
of the populations. Conclusions about selection based on
single marker FST values should be interpreted with cau-
tion [24]. Still, the FST estimates provide a practical por-
trayal of the adaptation processes of Puerto Ricans and
surely merit further research. Alternatively, genome-wide
genotyping using microarrays will allow detection of
selection signal at a genome scale based on an excess of
ancestral divergence between disease and non-disease
groups [25]. It will also be useful to increase the list of
tested markers and of biological pathways, as well as to
expand into other genetic measures such as linkage dise-
quilibrium in this Puerto Rican cohort. Finally, we
defined risk (or protective) allele based on studies on
other, often non-Hispanic, populations assuming these
alleles would exert the same impact in Puerto Ricans. The
amount of risk or protection conferred by a given allele or
the extent of change in a biomarker of disease status may
be different in Puerto Ricans, and further association stud-
ies should be done to corroborate this.
Alternatively, our study has several strengths. First, noting
that there are fluctuations in allele and genotype frequen-
cies in control populations by age and sex [43], we sought
to compare the two populations using data from individ-
uals within the same age range. We did not observe any
differences by sex. Second, our study has a fairly large
sample size. Taioli et al. showed that the deviation of the
estimate of allele frequency calculation from the true fre-
quency decreases with increasing sample size, with sam-
ple sizes above 500 having almost no deviation [15]. The
same principle applies to FST estimates. Third, Akey et al.
demonstrated that the average FST values could be affected
by genotyping error rates as low as 2–5% [39], but our
methods, validated repeatedly, produce less than a 1%
genotyping error rate, greatly decreasing the impact of
such errors in the FST estimates.
The results of this study have implications in the genera-
tion of new hypotheses and selection of candidate genes
for association studies and gene-environment interaction
studies. Allele frequency variations and FST patterns guide
BMC Genetics 2009, 10:45 http://www.biomedcentral.com/1471-2156/10/45
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the identification of markers that may have been more
prone to local adaptation by past environmental influ-
ences that contrast sharply with the environmental pres-
sures faced by Puerto Ricans living in Boston, MA at the
present time, namely poor nutritional habits [32]. Such
markers are more likely to respond to environmental sig-
nals in a manner that manifests as an association with dis-
ease status or progression. The observed differences in
allele frequency and population differentiation for dis-
ease-associated SNPs may explain the disparities in dis-
ease prevalence observed in Puerto Ricans. For example, it
has been shown that carriers of the variant allele of the
Pro12Ala polymorphism in the PPARG gene have a bene-
ficial effect on the measures of glucose metabolism with
higher fish intake [44]. Taínos (the Amerindian heritage
of modern Puerto Ricans) consumed a diet based on fish,
tropical fruits and vegetables, and some small animals
[45]. Today, major contributors to the Puerto Rican diet
are rice, starchy roots, milk, fried meat products, and proc-
essed, Westernized foods, with little consumption of fish
[46,47]. Interestingly, Puerto Ricans from our cohort had
significantly higher frequency of this minor allele than
NHW; yet the beneficial effect may have been lost with the
low consumption of fish in this population today. This
warrants assessment of the contribution of this, and other,
polymorphisms to the high prevalence of diabetes in
Puerto Ricans [4,48].
Clearly, the goal is to assess genetic and/or environmental
contribution to disease to help solve these disparities with
targeted interventions and not to create any bias against
the populations under study based on genetic profile. Sev-
eral examples of such ethnicity-based prospective inter-
ventions and drug therapies have been reported, such as
the population-specific drug-metabolizing capabilities
due to various polymorphisms in the cytochrome P450
(CYP450) enzymes [49]. Finally, this study does not
define Puerto Ricans on a genetic level, as they are already
a well-defined ethnic group with distinct cultural and
social norms and environmental influences, even while
sharing some characteristics with other Hispanic sub-
groups. Further studies on genetic and environmental
determinants of disease by ethnic or racial groups should
recognize the unique genetic and cultural traits of Puerto
Ricans.
Conclusion
Puerto Ricans have significantly different genotype and
allele frequency distributions than those of NHW for
SNPs in lipid and glucose metabolism, and inflammation
response. Puerto Ricans tend to carry risk minor alleles at
higher frequency and protective minor alleles at lower fre-
quency than the NHW population. Additionally, patterns
of population differentiation were different between the
two populations by SNP function. Characterizing the
genetic profile of Puerto Ricans will give a solid founda-
tion to the role of genetic variation in disease in an under-
studied population, support research of genetic
interactions with environmental contributors, and help
craft interventions to alleviate health disparities in Puerto
Ricans.
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